At the less severe end of the spectrum is
tuberculoid leprosy, which encompasses TT and BT disease. In general, these forms
of leprosy result in symptoms confined to the skin and peripheral nerves. The
skin lesions of tuberculoid leprosy consist of one or a few hypopigmented
macules or plaques that are sharply demarcated and hypesthetic, often have
erythematous or raised borders, and are devoid of the normal skin organs (sweat
glands and hair follicles) and thus are dry, scaly, and anhidrotic. AFB are
generally absent or few in number. Tuberculoid leprosy patients may have
asymmetric enlargement of one or a few peripheral nerves. Indeed, leprosy and
certain rare hereditary neuropathies are the only human diseases associated with
peripheral-nerve enlargement. Although any peripheral nerve may be enlarged
(including small digital and supraclavicular nerves), those most commonly
affected are the ulnar, posterior auricular, peroneal, and posterior tibial
nerves, with associated hypesthesia and myopathy. TT leprosy is the most common
form of the disease encountered in India and Africa but is virtually absent in
Southeast Asia, where BT leprosy is frequent.
In tuberculoid leprosy, T cells breach the
perineurium, and destruction of Schwann cells and axons may be evident,
resulting in fibrosis of the epineurium, replacement of the endoneurium with
epithelial granulomas, and occasionally caseous necrosis. Such invasion and
destruction of nerves in the dermis by T cells are pathognomonic for leprosy.
Circulating lymphocytes from patients with
tuberculoid leprosy readily recognize M. leprae and its constituent proteins, and
patients have positive lepromin skin tests (see “Diagnosis,” below). In
tuberculoid leprosy tissue, there is a 2:1 predominance of helper CD4+ over CD8+T lymphocytes. Tuberculoid tissues are rich in the mRNAs of the
proinflammatory TH1 family of cytokines: interleukin (IL) 2, interferon γ (IFN- γ), and IL-12;
in contrast, IL-4, IL-5, and IL-10 mRNAs are scarce.
Source:
Harrison_s_Principles_of_Internal_Medicine_16th_Edition
No comments:
Post a Comment